Cancer

Reimagine Care and Memorial Hermann Health System Unveil Expanded On-Demand Cancer Care Partnership

NASHVILLE, Tenn. & HOUSTON--(BUSINESS WIRE)--Reimagine Care, the nation’s leading provider of on-demand cancer care, and Memorial Hermann Health System, one…

1 year ago

Revolutionizing Breast Imaging: Rezolut Launches SecondReadAI(TM), powered by Lunit

ATLANTA, GA / ACCESSWIRE / August 28, 2024 / Rezolut, LLC, a pioneering leader in medical imaging technology, has unveiled…

1 year ago

Rutherrin(R) Increases Efficacy of Chemotherapy for Lung Cancer

TORONTO, ON / ACCESSWIRE / August 28, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage…

1 year ago

Correction: Cantargia Publishes Half-Year Report 2024

Correction of sign on three values in the Changes in working capital on page 16 of the report. Corrected values…

1 year ago

HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

NEW YORK and VIENNA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”, the “Company”), a company…

1 year ago

IMUNON to Host R&D Day on September 18th

R&D Discussion in New York City to Review IL-12’s Potential to Treat Ovarian Cancer Program Features Ovarian Cancer Thought Leaders,…

1 year ago

Mestag Therapeutics Awarded Significant Grant from Innovate UK’s Prestigious Cancer Therapeutics Program to Accelerate the Path to the Clinic for MST-0300

Mestag Therapeutics Employees of Cambridge, UK based Mestag Therapeutics - Innovate UK, part of UK Research and Innovation, is investing…

1 year ago

Tribun Health Partners With Ibex to Deliver Advanced AI Diagnostic Solutions

ARIS, FRANCE AND MONTREAL, QUEBEC / ACCESSWIRE / August 28, 2024 / Tribun Health, a leading provider of digital pathology…

1 year ago

Cantargia Publishes Half-Year Report 2024

LUND, SE / ACCESSWIRE / August 28, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB (publ); Nasdaq Stockholm:CANTA) today announced its…

1 year ago

AI-based Medical Device Company Imidex and Precision Genomix Company Orbit Genomics Form Strategic Relationship to Explore the Detection of Lung Cancer in Early Stages

Computer Vision AI and Precision Genomic Collaboration Aims to Increase Early Detection Rates, Improving Survival Chances for Millions DENVER, Aug.…

1 year ago